Skip to main content
. 2016 Feb 29;22:9. doi: 10.1186/s40885-016-0044-y

Table 6.

Clinical outcomes following BTK interventions in patients with CLI according to blood pressure control at 12 months

Variable. n% Total (n = 165 Pts) (n = 201 Limb) (n = 246 Lesion) Controlled HTN (n = 53 Pts) (n = 66 Limb) (n = 90 Lesion) Uncontrolled HTN (n = 112 Pts) (n = 135 Limb) (n = 156 Lesion) P Value
12-months clinical outcomes
Mortality 9 (5.4) 2 (3.7) 7 (6.2) 0.720
Cardiac death 5 (3.0) 1 (1.8) 4 (3.5) 1.000
TLR, Pts 18 (10.9) 6 (11.3) 12 (10.7) 0.907
TLR, Limb 21 (10.4) 6 (9) 15 (11.1) 0.808
TER, Pts 20 (12.1) 7 (13.2) 13 (11.6) 0.769
TER, Limb 25 (12.4) 7 (10.6) 18 (13.3) 0.655
Non TER 7 (4.2) 3 (5.7) 4 (3.6) 0.534
Amputations - Pts 40 (24.2) 18 (33.9) 22 (19.6) 0.045
Amputations - Limb 41 (20.3) 19 (28.7) 22 (16.2) 0.061
Major
above the knee 0 (0.0) 0 (0.0) 0 (0.0) 1.000
above the ankle - Pts 10 (6.0) 7 (13.2) 3 (2.6) 0.013
above the ankle - Limb 10 (4.9) 7 (10.6) 3 (2.2) 0.016
minor (below the ankle) - Pts 30 (18.1) 11 (20.7) 19 (16.9) 0.556
minor (below the ankle) - Limb 31 (15.4) 12 (18.1) 19 (14) 0.533
Myocardial infarction 2 (1.2) 1 (1.8) 1 (0.8) 0.541
PTCA 7 (4.2) 3 (5.6) 4 (3.5) 0.682
Cerebrovascular accidents 1 (0.6) 0 (0.0) 1 (0.8) 1.000
Limb salvage 147/156 (94.2) 45/51 (88.2) 102/105 (97.1) 0.059
Angiogram to follow-up 55 (33.3) 18 (33.9) 37 (33) 0.906
CT 21 (38.1) 8 (44.4) 13 (35.1) 0.505
PAG 42 (76.3) 13 (72.2) 29 (78.3) 0.738
Binary restenosis 35 (63.6) 11 (61.1) 24 (64.8) 0.786
Total re-occlusion 29 (52.7) 8 (44.4) 21 (56.7) 0.391
Primary patency 20 (36.3) 7 (38.8) 13 (35.1) 0.786
Secondary patency 39 (70.9) 11 (61.1) 28 (75.6) 0.264
Non-Total occlusion; Runoff (≥1) included Collateral, to distal 53 (96.3) 17 (94.4) 36 (97.2) 1.000

Values are mean ± SD (range). BTK indicates Below-the-knee artery, CLI critical limb ischemia, HTN hypertension, Pts patients, TLR target lesion revascularization, TER target extremity revascularization, PTCA percutaneous transluminal coronary angioplasty, CT computed tomography, PAG follow-up invasive peripheral angiography